7th Annual Individualized & Precision Medicine Conference to be held in Baltimore from Oct.
This Conference will be a thrilling opportunity to deliberate alongside numerous stakeholders and professionals regarding the ways that healthcare is being reshaped by individualized and precision medicine. This conference brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic watch of the precision medication landscape. Key topics as of this calendar year's Conference include: – Finding worth in pharmacogenomics – The challenge of adopting NGS panels – Making RNA sequencing actionable in the clinic – Integration of whole genome sequencing into clinical medication – Precision healthcare platforms – Balancing public and private intellectual property passions in a post Mayo-Myriad age – Precision medicine and policy in the building Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Great Begin GeneticsAmbry Genetics presents groundbreaking TP53 gene data at ASHG; TP53 linked to breast cancerApplying a high restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiFeatured Speakers include: Robert Green, MD, FACP, Director of Applied Genomics Analysis Informatics, Director, Health Heritage Family Medical History Project, Middle for Biomedical Research Informatics at NorthShore University Analysis Institute Gitte Pederson, CEO at Genomic Expression Anya Schiess, MBA, General Co-Founder and Partner at Healthful Ventures Paul Sheives, JD, Vice President, Reimbursement & Regulatory Plan at American Clinical Laboratory Association Elaine Cheung, Director of Strategic Partnerships at Illumina Angela Davies, MD, FRCP , Chief Medical Officer at Champions Oncology Tag Gerstein, Ph.D., Professor of Biomedical Informatics at Yale University Laura Lyman Rodriquez, Ph.D., Director, Office of Policy, Education and Communications at National Individual Genome Research Institute Jen Madsen, MPH, Health Plan Advisor at Arnold & Porter Ken Ramos, MD, Ph.D., PharmB, Associate Vice President for Precision Health Sciences, Professor of Medication at Arizona Wellness Sciences Middle Birgit Reitmaier, Ph.D., Head of Technologies & Biomarkers, Global Licensing & Business Advancement at Merck Serono division, Merck KGaA..Registration before Aug. 15 is $125 for physicians; $35 for learners; and $100 for all others. Valid identification must be eligible for registration categories.
ACP releases paper promoting increased financing for FDA ACP offers series of suggestions to expand authorityA new policy paper that calls for broader authority and increased financing for the Food and Medication Administration premiered today by the American College of Physicians .